Tariquidar

Tariquidar
Systematic (IUPAC) name

N-[2-[[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide
Clinical data
Identifiers
CAS Registry Number	206873-63-4^Y
ATC code	None
PubChem	CID 148201
ChemSpider	130650^N
UNII	J58862DTVD^Y
ChEMBL	CHEMBL348475^N
Chemical data
Formula	C₃₈H₃₈N₄O₆
Molecular mass	646.73 g/mol
SMILES COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC
InChI InChI=1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43) ^N Key:LGGHDPFKSSRQNS-UHFFFAOYSA-N ^N
N (what is this?) (verify)

Tariquidar (INN/USAN) is a P-glycoprotein inhibitor^[1] undergoing research as an adjuvant against multidrug resistance in cancer.

References

↑ Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE. Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). Biochem Pharmacol 2008;3:1302-12. PMID 18234154.